candidate_genes,disease,celltype,y,user_question,full_query
"['SOWAHB', 'ABCC3', 'HGF', 'TYMS', 'OSBPL7']",Hepatoblastoma,endothelial,TYMS,"Among SOWAHB, ABCC3, HGF, TYMS, and OSBPL7, which gene exhibits the highest specificity in endothelial cells for targeted therapy against hepatoblastoma?","Among SOWAHB, ABCC3, HGF, TYMS, and OSBPL7, which gene exhibits the highest specificity in endothelial cells for targeted therapy against hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, identify the overlap between these therapeutic targets and the endothelial-activated genes cataloged in PINNACLE. For the overlapping gene set, compute the average embedding and then calculate the cosine similarity between this reference embedding and that of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['TUBB', 'CLEC12B', 'TRPC3', 'NDUFAB1', 'BLOC1S4']",Hepatoblastoma,endothelial,TUBB,"Among TUBB, CLEC12B, TRPC3, NDUFAB1, and BLOC1S4, which gene exhibits the highest specificity in endothelial cells for targeted intervention in hepatoblastoma?","Among TUBB, CLEC12B, TRPC3, NDUFAB1, and BLOC1S4, which gene exhibits the highest specificity in endothelial cells for targeted intervention in hepatoblastoma? Identify validated therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the endothelial-activated genes identified in PINNACLE, thereby defining a subset of cell-type–specific therapeutic candidates. Compute the average embedding of this subset, then calculate the cosine similarity between this average and each individual target. If a single gene exhibits a distinctly higher similarity than all others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological significance."
"['POLD3', 'SFXN4', 'NPIPA1', 'ERO1A', 'HIVEP2']",Hepatoblastoma,endothelial,POLD3,"Which gene among POLD3, SFXN4, NPIPA1, ERO1A, and HIVEP2 exhibits the highest endothelial cell-type specificity for targeting hepatoblastoma?","Which gene among POLD3, SFXN4, NPIPA1, ERO1A, and HIVEP2 exhibits the highest endothelial cell-type specificity for targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and extract their cell-type specific embeddings from PINNACLE. Next, determine which endothelial-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type specific targets for hepatoblastoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene consistently exhibits a higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NPW', 'CX3CL1', 'PRR30', 'RND3', 'FLT1']",Hepatoblastoma,endothelial,FLT1,"Which gene among NPW, CX3CL1, PRR30, RND3, and FLT1 exhibits the highest endothelial cell specificity in the context of hepatoblastoma targeting?","Which gene among NPW, CX3CL1, PRR30, RND3, and FLT1 exhibits the highest endothelial cell specificity in the context of hepatoblastoma targeting? Identify validated therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which targets overlap with endothelial-activated genes in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and the individual embeddings of each target. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYH14', 'RRM1', 'ARHGEF19', 'BBS5', 'LITAF']",Hepatoblastoma,endothelial,RRM1,"Which gene among MYH14, RRM1, ARHGEF19, BBS5, and LITAF exhibits the highest endothelial cell-type specificity, making it the most promising candidate for targeting hepatoblastoma?","Which gene among MYH14, RRM1, ARHGEF19, BBS5, and LITAF exhibits the highest endothelial cell-type specificity, making it the most promising candidate for targeting hepatoblastoma? Identify the verified therapeutic targets for Hepatoblastoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the set of endothelial-activated genes listed in PINNACLE to define the cell-type–specific targets for Hepatoblastoma. Compute the average embedding for this gene set and calculate the cosine similarity between this reference and each individual target. Finally, if one gene demonstrates a significantly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TEAD3', 'SEC31A', 'BLNK', 'TOP1', 'CCIN']",Hepatoblastoma,endothelial,TOP1,"Among the genes TEAD3, SEC31A, BLNK, TOP1, and CCIN, which one exhibits the highest endothelial cell-specific expression for targeting hepatoblastoma?","Among the genes TEAD3, SEC31A, BLNK, TOP1, and CCIN, which one exhibits the highest endothelial cell-specific expression for targeting hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma using PINNACLE and extract the corresponding cell-type–specific embeddings. Next, determine which of the endothelial activation genes in PINNACLE overlap with these targets, thus defining the cell-type–specific targets for Hepatoblastoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average reference and each individual gene’s embedding. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FLT4', 'SOBP', 'ADAM21', 'UQCR10', 'SLCO4A1']",Hepatoblastoma,endothelial,FLT4,"Among the genes FLT4, SOBP, ADAM21, UQCR10, and SLCO4A1, which one exhibits the highest specificity toward endothelial cells for targeting hepatoblastoma?","Among the genes FLT4, SOBP, ADAM21, UQCR10, and SLCO4A1, which one exhibits the highest specificity toward endothelial cells for targeting hepatoblastoma? Determine the verified therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Identify which of these targets overlap with endothelial-activated genes in PINNACLE, and define this overlapping set as the cell-type–specific targets for hepatoblastoma. Calculate the average embedding for this set, then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SGCZ', 'KIAA0895L', 'EEA1', 'CSN1S1', 'PRIM1']",Hepatoblastoma,endothelial,PRIM1,"Which gene among SGCZ, KIAA0895L, EEA1, CSN1S1, and PRIM1 shows the highest endothelial cell specificity for targeting hepatoblastoma?","Which gene among SGCZ, KIAA0895L, EEA1, CSN1S1, and PRIM1 shows the highest endothelial cell specificity for targeting hepatoblastoma? Identify the verified therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the set of endothelial-activated genes in PINNACLE, and compute the average embedding for this overlapping group. Next, calculate the cosine similarity between this average and each individual target embedding. If one gene shows a clearly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CPNE4', 'DCTN5', 'PRIM2', 'KIAA1522', 'CCDC82']",Hepatoblastoma,endothelial,PRIM2,"Which gene among CPNE4, DCTN5, PRIM2, KIAA1522, and CCDC82 exhibits the highest endothelial cell-type specificity for targeting hepatoblastoma?","Which gene among CPNE4, DCTN5, PRIM2, KIAA1522, and CCDC82 exhibits the highest endothelial cell-type specificity for targeting hepatoblastoma? Identify the confirmed therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial-activated genes in PINNACLE intersect with these targets to define cell-type–specific targets for Hepatoblastoma. Compute the average embedding of this intersection to serve as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based explanation for its biological relevance."
"['RHPN1', 'THRB', 'PEPD', 'MAX', 'TOP2B']",Hepatoblastoma,endothelial,TOP2B,"Among the genes RHPN1, THRB, PEPD, MAX, and TOP2B, which one exhibits the highest specificity in endothelial cells for targeting Hepatoblastoma?","Among the genes RHPN1, THRB, PEPD, MAX, and TOP2B, which one exhibits the highest specificity in endothelial cells for targeting Hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Determine which endothelial-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for hepatoblastoma. Next, compute the average embedding for these overlapping genes as a reference and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RPP25', 'MMP10', 'POLD2', 'POLR2I', 'SUCNR1']",Hepatoblastoma,endothelial,POLD2,"Which gene among RPP25, MMP10, POLD2, POLR2I, and SUCNR1 demonstrates the greatest endothelial cell-type specificity, making it the most promising candidate for targeted intervention in hepatoblastoma?","Which gene among RPP25, MMP10, POLD2, POLR2I, and SUCNR1 demonstrates the greatest endothelial cell-type specificity, making it the most promising candidate for targeted intervention in hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the endothelial-activated genes in PINNACLE that overlap with these targets to define the cell-type–specific targets for hepatoblastoma. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this reference embedding and the embedding of each individual target gene. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['THOC2', 'TUBG2', 'POLE2', 'RPL5', 'CLDN7']",Hepatoblastoma,endothelial,POLE2,"Among the candidate genes THOC2, TUBG2, POLE2, RPL5, and CLDN7, which exhibits the highest specificity for endothelial cells in hepatoblastoma?","Among the candidate genes THOC2, TUBG2, POLE2, RPL5, and CLDN7, which exhibits the highest specificity for endothelial cells in hepatoblastoma? Identify the validated therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Determine the overlap between these targets and the endothelial-activated genes in PINNACLE to define the cell-type–specific targets for hepatoblastoma. Next, calculate the average embedding for the overlapping gene set and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TOP2A', 'ZNF823', 'DGKA', 'PRMT7', 'PDIA6']",Hepatoblastoma,endothelial,TOP2A,"Among TOP2A, ZNF823, DGKA, PRMT7, and PDIA6, which gene exhibits the highest endothelial cell-type specificity for targeting Hepatoblastoma?","Among TOP2A, ZNF823, DGKA, PRMT7, and PDIA6, which gene exhibits the highest endothelial cell-type specificity for targeting Hepatoblastoma? Identify the validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the endothelial-activated genes in PINNACLE to define a set of cell-type–specific candidate targets. Calculate the average embedding of these candidate targets as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TUBB4B', 'GNG10', 'CTPS2', 'NFE4', 'NFKB1']",Hepatoblastoma,endothelial,TUBB4B,"Which gene among TUBB4B, GNG10, CTPS2, NFE4, and NFKB1 exhibits the highest specificity for endothelial cells, thereby emerging as the most promising candidate for targeting hepatoblastoma?","Which gene among TUBB4B, GNG10, CTPS2, NFE4, and NFKB1 exhibits the highest specificity for endothelial cells, thereby emerging as the most promising candidate for targeting hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which endothelial-activated genes in PINNACLE overlap with these targets to define the cell-type–specific set for Hepatoblastoma. Compute the average embedding for the overlapping genes as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene displays a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KIT', 'TRABD', 'IGFBP3', 'KIF7', 'NANOG']",Hepatoblastoma,endothelial,KIT,"Which gene among KIT, TRABD, IGFBP3, KIF7, and NANOG exhibits the highest endothelial cell-specific expression for targeted intervention in hepatoblastoma?","Which gene among KIT, TRABD, IGFBP3, KIF7, and NANOG exhibits the highest endothelial cell-specific expression for targeted intervention in hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the subset of these targets that overlaps with endothelial-activated genes in PINNACLE, thereby defining hepatoblastoma-specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average embedding and each target’s embedding. If one gene consistently shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SOCS1', 'STX3', 'CFAP97', 'POLE3', 'SERTAD3']",Hepatoblastoma,endothelial,POLE3,"Which gene among SOCS1, STX3, CFAP97, POLE3, and SERTAD3 exhibits the highest endothelial cell specificity as a potential target for hepatoblastoma therapy?","Which gene among SOCS1, STX3, CFAP97, POLE3, and SERTAD3 exhibits the highest endothelial cell specificity as a potential target for hepatoblastoma therapy? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the endothelial-activated gene set in PINNACLE, as this overlap represents the cell-type–specific targets for Hepatoblastoma. Compute the average embedding of this overlapping set to serve as a reference, and then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['KDR', 'ADRB2', 'TMEM201', 'CHD6', 'EGFLAM']",Hepatoblastoma,endothelial,KDR,"Which gene among KDR, ADRB2, TMEM201, CHD6, and EGFLAM exhibits the most specific expression in endothelial cells to serve as a promising target for Hepatoblastoma therapy?","Which gene among KDR, ADRB2, TMEM201, CHD6, and EGFLAM exhibits the most specific expression in endothelial cells to serve as a promising target for Hepatoblastoma therapy? Identify the verified therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial-activated genes present in PINNACLE, which will define the cell-type–specific targets for hepatoblastoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LINC00839', 'VPREB3', 'ANKRD10', 'PTP4A1', 'KDR']",Hepatoblastoma,endothelial,KDR,"Among LINC00839, VPREB3, ANKRD10, PTP4A1, and KDR, which gene exhibits the highest endothelial cell-type specificity for hepatoblastoma targeting?","Among LINC00839, VPREB3, ANKRD10, PTP4A1, and KDR, which gene exhibits the highest endothelial cell-type specificity for hepatoblastoma targeting? Identify the validated therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the endothelial-activated genes in PINNACLE, defining the cell-type–specific targets for Hepatoblastoma. Calculate the average embedding for these targets and compute the cosine similarity between this average and each individual target embedding. If one target exhibits a significantly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based explanation of its biological relevance."
"['RPSAP15', 'KDM1A', 'NCS1', 'NDUFS5', 'FLT4']",Hepatoblastoma,endothelial,FLT4,"Which gene among RPSAP15, KDM1A, NCS1, NDUFS5, and FLT4 exhibits the highest endothelial cell specificity for targeted intervention in hepatoblastoma?","Which gene among RPSAP15, KDM1A, NCS1, NDUFS5, and FLT4 exhibits the highest endothelial cell specificity for targeted intervention in hepatoblastoma? Identify the validated therapeutic targets for hepatoblastoma and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the endothelial-activated genes in PINNACLE to define the cell-type-specific targets for hepatoblastoma. Calculate the average embedding for this overlapping set as a reference, and then compute the cosine similarity between the reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MRPL45', 'S1PR5', 'TYMS', 'ZNF155', 'TIMM13']",Hepatoblastoma,endothelial,TYMS,"Which gene among MRPL45, S1PR5, TYMS, ZNF155, and TIMM13 exhibits the highest endothelial cell-type specificity for targeted hepatoblastoma therapy?","Which gene among MRPL45, S1PR5, TYMS, ZNF155, and TIMM13 exhibits the highest endothelial cell-type specificity for targeted hepatoblastoma therapy? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial-activated genes in PINNACLE overlap with these targets to establish a set of cell-type–specific candidates. Compute the average embedding for this candidate set and then calculate the cosine similarity between this average and each individual candidate embedding. If one gene exhibits a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['METTL21C', 'SVIP', 'TUBB', 'DEFB131A', 'CMYA5']",Hepatoblastoma,kupffer cell,TUBB,"Which gene among METTL21C, SVIP, TUBB, DEFB131A, and CMYA5 exhibits the highest expression specificity in Kupffer cells for targeted intervention in hepatoblastoma?","Which gene among METTL21C, SVIP, TUBB, DEFB131A, and CMYA5 exhibits the highest expression specificity in Kupffer cells for targeted intervention in hepatoblastoma? Identify the verified therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of kupffer cell–activated genes from PINNACLE, thereby defining the cell-type–specific targets for Hepatoblastoma. Calculate the average embedding for this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PLAAT5', 'TOP2A', 'UPF2', 'MSH5', 'PRKAG2']",Hepatoblastoma,kupffer cell,TOP2A,"Among the genes PLAAT5, TOP2A, UPF2, MSH5, and PRKAG2, which one exhibits the most specific expression in Kupffer cells for targeted intervention in Hepatoblastoma?","Among the genes PLAAT5, TOP2A, UPF2, MSH5, and PRKAG2, which one exhibits the most specific expression in Kupffer cells for targeted intervention in Hepatoblastoma? Identify verified therapeutic target genes for hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which of the kupffer cell-activated genes in PINNACLE overlap with these targets, as this set represents the cell-type–specific targets. Calculate the average embedding of this overlapping set to serve as a reference, and compute the cosine similarity between this reference and each individual target's embedding. If one gene shows significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLD3', 'PDZK1IP1', 'TMEM120A', 'ITPRIP', 'RGS16']",Hepatoblastoma,kupffer cell,POLD3,"Among the genes POLD3, PDZK1IP1, TMEM120A, ITPRIP, and RGS16, which one exhibits the highest specificity in Kupffer cells, making it the most promising candidate for targeting hepatoblastoma?","Among the genes POLD3, PDZK1IP1, TMEM120A, ITPRIP, and RGS16, which one exhibits the highest specificity in Kupffer cells, making it the most promising candidate for targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which Kupffer cell–activated genes from PINNACLE overlap with these targets, treating this overlapping set as the cell-type–specific targets for hepatoblastoma. Calculate the average embedding for the overlapping set and determine the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDH18', 'TOP2B', 'TIGD7', 'POLR3H', 'KRTAP5-7']",Hepatoblastoma,kupffer cell,TOP2B,"Which gene—CDH18, TOP2B, TIGD7, POLR3H, or KRTAP5-7—exhibits the highest cell-type specificity in Kupffer cells, making it the most promising target for hepatoblastoma therapy?","Which gene—CDH18, TOP2B, TIGD7, POLR3H, or KRTAP5-7—exhibits the highest cell-type specificity in Kupffer cells, making it the most promising target for hepatoblastoma therapy? Identify the validated therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in Kupffer cells in PINNACLE; these represent the cell-type–specific targets. Compute the average embedding of these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TYMS', 'ZNRD2', 'RPLP0', 'MRI1', 'TRIM9']",Hepatoblastoma,kupffer cell,TYMS,"Among TYMS, ZNRD2, RPLP0, MRI1, and TRIM9, which gene exhibits the highest specificity of expression in Kupffer cells, making it the most suitable candidate for targeted intervention in hepatoblastoma?","Among TYMS, ZNRD2, RPLP0, MRI1, and TRIM9, which gene exhibits the highest specificity of expression in Kupffer cells, making it the most suitable candidate for targeted intervention in hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes activated in Kupffer cells overlap with these targets; this overlapping set will serve as the cell-type–specific targets for hepatoblastoma. Calculate the average embedding for this set and then compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['LRRC8E', 'GK', 'PTGR2', 'EHF', 'POLA2']",Hepatoblastoma,kupffer cell,POLA2,"Among the genes LRRC8E, GK, PTGR2, EHF, and POLA2, which one shows the highest specificity of expression in Kupffer cells for potential targeting of hepatoblastoma?","Among the genes LRRC8E, GK, PTGR2, EHF, and POLA2, which one shows the highest specificity of expression in Kupffer cells for potential targeting of hepatoblastoma? Identify the validated therapeutic targets for hepatoblastoma and obtain their cell-type-specific embeddings from PINNACLE. Next, retrieve the set of kupffer cell-activated genes from PINNACLE and determine which of these overlap with the hepatoblastoma targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference embedding and each individual target. If one gene consistently shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HJV', 'TUBB4B', 'MMP2', 'NRCAM', 'CBL']",Hepatoblastoma,kupffer cell,TUBB4B,"Which gene among HJV, TUBB4B, MMP2, NRCAM, and CBL exhibits the highest expression specificity in Kupffer cells, making it the most promising candidate for targeted hepatoblastoma therapy?","Which gene among HJV, TUBB4B, MMP2, NRCAM, and CBL exhibits the highest expression specificity in Kupffer cells, making it the most promising candidate for targeted hepatoblastoma therapy? Identify and retrieve the verified therapeutic targets for Hepatoblastoma from PINNACLE, along with their cell-type–specific embeddings. Next, determine which kupffer cell-activated genes in PINNACLE overlap with these targets to define a cell-type–specific target set. Compute the average embedding for this set and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KIR3DL2', 'RRM1', 'ALOX12', 'NAGS', 'USP37']",Hepatoblastoma,kupffer cell,RRM1,"Among the genes KIR3DL2, RRM1, ALOX12, NAGS, and USP37, which one exhibits the highest specificity for Kupffer cells in the context of targeting hepatoblastoma?","Among the genes KIR3DL2, RRM1, ALOX12, NAGS, and USP37, which one exhibits the highest specificity for Kupffer cells in the context of targeting hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which kupffer cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of the overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['DNASE1', 'RAPGEF1', 'POLE2', 'TSHB', 'TRIM48']",Hepatoblastoma,kupffer cell,POLE2,"Among DNASE1, RAPGEF1, POLE2, TSHB, and TRIM48, which gene exhibits the greatest cell-type specificity in Kupffer cells, making it the most promising candidate for targeted hepatoblastoma interventions?","Among DNASE1, RAPGEF1, POLE2, TSHB, and TRIM48, which gene exhibits the greatest cell-type specificity in Kupffer cells, making it the most promising candidate for targeted hepatoblastoma interventions? Identify validated therapeutic targets for hepatoblastoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Cross-reference these targets with the set of kupffer cell-activated genes in PINNACLE to determine the overlapping genes, which will serve as the cell-type–specific targets for hepatoblastoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual gene's embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PMF1-BGLAP', 'WDR20', 'ELK4', 'BEGAIN', 'PRIM2']",Hepatoblastoma,kupffer cell,PRIM2,"Among PMF1-BGLAP, WDR20, ELK4, BEGAIN, and PRIM2, which gene shows the highest expression specificity in Kupffer cells, making it the most promising candidate for hepatoblastoma targeting?","Among PMF1-BGLAP, WDR20, ELK4, BEGAIN, and PRIM2, which gene shows the highest expression specificity in Kupffer cells, making it the most promising candidate for hepatoblastoma targeting? Identify the validated therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the intersection of these targets with kupffer cell–activated genes in PINNACLE. Compute the average embedding of the overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPG11', 'NCOA5', 'FLT1', 'SHF', 'CYTH2']",Hepatoblastoma,kupffer cell,FLT1,"Which gene—SPG11, NCOA5, FLT1, SHF, or CYTH2—exhibits the highest specificity for Kupffer cells in the context of hepatoblastoma targeting?","Which gene—SPG11, NCOA5, FLT1, SHF, or CYTH2—exhibits the highest specificity for Kupffer cells in the context of hepatoblastoma targeting? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which Kupffer cell–activated genes in PINNACLE overlap with these targets, forming a set of candidate cell-type–specific targets. Compute the average embedding for these candidates and calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRIM1', 'SUCO', 'TUBGCP4', 'MAPK13', 'ZNF580']",Hepatoblastoma,kupffer cell,PRIM1,"Among PRIM1, SUCO, TUBGCP4, MAPK13, and ZNF580, which gene shows the highest expression specificity in Kupffer cells for potential hepatoblastoma targeting?","Among PRIM1, SUCO, TUBGCP4, MAPK13, and ZNF580, which gene shows the highest expression specificity in Kupffer cells for potential hepatoblastoma targeting? Identify the verified therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the Kupffer cell-activated genes cataloged in PINNACLE. For the overlapping genes, compute the average embedding as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene consistently shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TOP1', 'PILRB', 'AKAP1', 'DHODH', 'REG1A']",Hepatoblastoma,kupffer cell,TOP1,"Among TOP1, PILRB, AKAP1, DHODH, and REG1A, which gene demonstrates the highest cell-type specificity in kupffer cells and therefore represents the most promising target for hepatoblastoma?","Among TOP1, PILRB, AKAP1, DHODH, and REG1A, which gene demonstrates the highest cell-type specificity in kupffer cells and therefore represents the most promising target for hepatoblastoma? Identify validated therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which kupffer cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for Hepatoblastoma. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference and each individual target. If a single gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PEG10', 'CFAP100', 'POLA1', 'ZNF141', 'DPAGT1']",Hepatoblastoma,kupffer cell,POLA1,"Among the genes PEG10, CFAP100, POLA1, ZNF141, and DPAGT1, which one exhibits the highest specificity in Kupffer cells and would therefore be the most promising candidate for targeted hepatoblastoma therapy?","Among the genes PEG10, CFAP100, POLA1, ZNF141, and DPAGT1, which one exhibits the highest specificity in Kupffer cells and would therefore be the most promising candidate for targeted hepatoblastoma therapy? Identify validated therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine which targets overlap with genes activated in Kupffer cells from the same dataset. For the overlapping gene set, compute the average embedding vector and calculate the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['B3GNT8', 'VGF', 'ARHGAP17', 'PRIM2', 'TRIB2']",Hepatoblastoma,kupffer cell,PRIM2,"Which gene among B3GNT8, VGF, ARHGAP17, PRIM2, and TRIB2 exhibits the highest specificity for Kupffer cells, thereby representing the best target for hepatoblastoma?","Which gene among B3GNT8, VGF, ARHGAP17, PRIM2, and TRIB2 exhibits the highest specificity for Kupffer cells, thereby representing the best target for hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which kupffer cell-activated genes overlap with these targets to establish a set of cell-type–specific targets for hepatoblastoma. Compute the average embedding of this overlapping gene set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RXFP1', 'RAB5IF', 'HOXA7', 'TUBB4B', 'PPEF1']",Hepatoblastoma,kupffer cell,TUBB4B,"Among the genes RXFP1, RAB5IF, HOXA7, TUBB4B, and PPEF1, which one demonstrates the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma?","Among the genes RXFP1, RAB5IF, HOXA7, TUBB4B, and PPEF1, which one demonstrates the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which kupffer cell–activated genes in PINNACLE overlap with these targets to define cell-type–specific therapeutic targets. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PTPN1', 'ALPL', 'SALL1', 'POLD3', 'REPS2']",Hepatoblastoma,kupffer cell,POLD3,"Which gene among PTPN1, ALPL, SALL1, POLD3, and REPS2 exhibits the highest cell-type specificity in Kupffer cells for hepatoblastoma targeting?","Which gene among PTPN1, ALPL, SALL1, POLD3, and REPS2 exhibits the highest cell-type specificity in Kupffer cells for hepatoblastoma targeting? Identify the validated therapeutic targets for Hepatoblastoma using PINNACLE and extract their corresponding cell‐type specific embeddings. Next, find the overlap between these targets and the genes activated in kupffer cells according to PINNACLE data. Calculate the average embedding of the overlapping set and compute the cosine similarity between this average and each individual target’s embedding. Finally, determine if one gene has a significantly higher similarity than the others, nominate it as the prime candidate, and provide a concise, evidence‐based explanation for its biological relevance."
"['MARK2', 'KRT9', 'CXCL13', 'RHOV', 'TUBB']",Hepatoblastoma,kupffer cell,TUBB,"Among the genes MARK2, KRT9, CXCL13, RHOV, and TUBB, which exhibits the highest cell-type specificity in Kupffer cells for potential targeted intervention in Hepatoblastoma?","Among the genes MARK2, KRT9, CXCL13, RHOV, and TUBB, which exhibits the highest cell-type specificity in Kupffer cells for potential targeted intervention in Hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which Kupffer cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific therapeutic set. Compute the average embedding for these overlapping genes and then calculate the cosine similarity between this average and the individual target embeddings. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OR7D4', 'SLC12A4', 'AAMP', 'PRIM1', 'THRSP']",Hepatoblastoma,kupffer cell,PRIM1,"Among the genes OR7D4, SLC12A4, AAMP, PRIM1, and THRSP, which exhibits the highest cell-type specificity in Kupffer cells and represents the most promising candidate for targeted hepatoblastoma therapy?","Among the genes OR7D4, SLC12A4, AAMP, PRIM1, and THRSP, which exhibits the highest cell-type specificity in Kupffer cells and represents the most promising candidate for targeted hepatoblastoma therapy? Identify verified therapeutic targets for hepatoblastoma and retrieve their cell type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the kupffer cell–activated genes present in PINNACLE, and compute the average embedding of the overlapping set. Then, calculate the cosine similarity between this average embedding and the embedding of each individual target gene. If one gene exhibits a considerably higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['WIPF2', 'CSF1', 'FUT11', 'POLE2', 'IFT80']",Hepatoblastoma,kupffer cell,POLE2,"Among the genes WIPF2, CSF1, FUT11, POLE2, and IFT80, which exhibits the highest cell-type specificity in Kupffer cells for hepatoblastoma targeting?","Among the genes WIPF2, CSF1, FUT11, POLE2, and IFT80, which exhibits the highest cell-type specificity in Kupffer cells for hepatoblastoma targeting? Identify validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in kupffer cells within PINNACLE. Compute the average embedding of these overlapping genes and then calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene shows a clearly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its potential biological relevance in hepatoblastoma."
"['BOLA2B', 'POLR3B', 'PRIM2', 'NCOA5', 'ILKAP']",Hepatoblastoma,hepatic stellate cell,PRIM2,"Which gene among BOLA2B, POLR3B, PRIM2, NCOA5, and ILKAP shows the highest cell-type specificity in hepatic stellate cells, making it the prime candidate for targeting hepatoblastoma?","Which gene among BOLA2B, POLR3B, PRIM2, NCOA5, and ILKAP shows the highest cell-type specificity in hepatic stellate cells, making it the prime candidate for targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which hepatic stellate cell‐activated genes in PINNACLE overlap with these targets to form the set of cell-type–specific candidates. Compute the average embedding for these candidates as a reference vector and calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['SMARCA4', 'TTC7B', 'CARD8', 'TOP1', 'SNX9']",Hepatoblastoma,hepatic stellate cell,TOP1,"Which gene among SMARCA4, TTC7B, CARD8, TOP1, and SNX9 exhibits the highest specificity for hepatic stellate cells, making it the most suitable target for therapeutic intervention in hepatoblastoma?","Which gene among SMARCA4, TTC7B, CARD8, TOP1, and SNX9 exhibits the highest specificity for hepatic stellate cells, making it the most suitable target for therapeutic intervention in hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, find the overlap between these targets and the hepatic stellate cell–activated genes in PINNACLE. For the overlapping gene set, compute the average embedding and then determine the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate, and provide a concise evidence-based rationale for its biological relevance."
"['TANK', 'WDR73', 'SPP1', 'LAMA5', 'TOP2B']",Hepatoblastoma,hepatic stellate cell,TOP2B,"Which gene among TANK, WDR73, SPP1, LAMA5, and TOP2B demonstrates the highest cell-type specificity in hepatic stellate cells, making it the most appropriate candidate for targeting hepatoblastoma?","Which gene among TANK, WDR73, SPP1, LAMA5, and TOP2B demonstrates the highest cell-type specificity in hepatic stellate cells, making it the most appropriate candidate for targeting hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in hepatic stellate cells. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CD177', 'PDIA5', 'TUBB', 'MPHOSPH8', 'RPL27']",Hepatoblastoma,hepatic stellate cell,TUBB,"Among the genes CD177, PDIA5, TUBB, MPHOSPH8, and RPL27, which one demonstrates the highest specificity within hepatic stellate cells, making it the most appropriate target for hepatoblastoma?","Among the genes CD177, PDIA5, TUBB, MPHOSPH8, and RPL27, which one demonstrates the highest specificity within hepatic stellate cells, making it the most appropriate target for hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, compare these targets with the genes activated in hepatic stellate cells within PINNACLE to define the overlapping set as cell-type–specific targets for Hepatoblastoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference embedding and the embedding of each individual target. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based explanation for its biological relevance."
"['CYB5R2', 'TOP2A', 'ZSCAN10', 'DHODH', 'GEMIN4']",Hepatoblastoma,hepatic stellate cell,TOP2A,"Which gene among CYB5R2, TOP2A, ZSCAN10, DHODH, and GEMIN4 demonstrates the highest cell-type specificity in hepatic stellate cells for hepatoblastoma targeting?","Which gene among CYB5R2, TOP2A, ZSCAN10, DHODH, and GEMIN4 demonstrates the highest cell-type specificity in hepatic stellate cells for hepatoblastoma targeting? Retrieve the validated therapeutic targets for hepatoblastoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, identify the subset of hepatic stellate cell-activated genes in PINNACLE that overlap with these targets to define the cell-type–specific hepatoblastoma target set. Compute the average embedding for this set and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CKB', 'SEC24A', 'MEPCE', 'TYMS', 'B3GAT1']",Hepatoblastoma,hepatic stellate cell,TYMS,"Which gene among CKB, SEC24A, MEPCE, TYMS, and B3GAT1 exhibits the highest cell-type specificity in hepatic stellate cells for potential therapeutic targeting of hepatoblastoma?","Which gene among CKB, SEC24A, MEPCE, TYMS, and B3GAT1 exhibits the highest cell-type specificity in hepatic stellate cells for potential therapeutic targeting of hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the hepatic stellate cell–activated genes in PINNACLE to define the cell-type–specific targets for hepatoblastoma. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PANK4', 'TUBAL3', 'PDGFRB', 'PLA2G6', 'NDUFAF6']",Hepatoblastoma,hepatic stellate cell,PDGFRB,"Which gene—PANK4, TUBAL3, PDGFRB, PLA2G6, or NDUFAF6—exhibits the highest specificity for hepatic stellate cells, making it the most promising target for hepatoblastoma therapy?","Which gene—PANK4, TUBAL3, PDGFRB, PLA2G6, or NDUFAF6—exhibits the highest specificity for hepatic stellate cells, making it the most promising target for hepatoblastoma therapy? Identify and verify therapeutic targets for hepatoblastoma using cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in hepatic stellate cells in PINNACLE overlap with these targets. Calculate the average embedding of this overlapping gene set to serve as a reference, then compute the cosine similarity between this reference and the embedding of each candidate target. If one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ARL8A', 'MAX', 'RACGAP1', 'NAE1', 'FLT1']",Hepatoblastoma,hepatic stellate cell,FLT1,"Among the genes ARL8A, MAX, RACGAP1, NAE1, and FLT1, which one demonstrates the highest specificity for hepatic stellate cells, making it the optimal candidate for targeted hepatoblastoma therapy?","Among the genes ARL8A, MAX, RACGAP1, NAE1, and FLT1, which one demonstrates the highest specificity for hepatic stellate cells, making it the optimal candidate for targeted hepatoblastoma therapy? Using validated therapeutic targets for hepatoblastoma, retrieve their cell-type–specific embeddings from the PINNACLE dataset. Identify which of these targets overlap with hepatic stellate cell–activated genes, and compute the average embedding of this overlapping set as the reference. Then, calculate the cosine similarity between the reference embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise evidence-based explanation for its biological relevance."
"['SORBS1', 'SAMD3', 'FLT1', 'TSNARE1', 'SPACA6']",Hepatoblastoma,hepatic stellate cell,FLT1,"Which gene among SORBS1, SAMD3, FLT1, TSNARE1, and SPACA6 exhibits the highest cell-type specificity in hepatic stellate cells for potential targeting in hepatoblastoma?","Which gene among SORBS1, SAMD3, FLT1, TSNARE1, and SPACA6 exhibits the highest cell-type specificity in hepatic stellate cells for potential targeting in hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with genes activated in hepatic stellate cells. For the overlapping genes, compute their average embedding and then calculate the cosine similarity of each individual embedding to this reference. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['RPS15A', 'PLPPR1', 'MRPL28', 'RPGRIP1L', 'TOP1']",Hepatoblastoma,hepatic stellate cell,TOP1,"Which gene among RPS15A, PLPPR1, MRPL28, RPGRIP1L, and TOP1 exhibits the highest cell-type specificity in hepatic stellate cells for targeted intervention in hepatoblastoma?","Which gene among RPS15A, PLPPR1, MRPL28, RPGRIP1L, and TOP1 exhibits the highest cell-type specificity in hepatic stellate cells for targeted intervention in hepatoblastoma? Using validated therapeutic targets for Hepatoblastoma, retrieve their cell-type–specific embeddings from the PINNACLE database. Among these, identify the genes activated in hepatic stellate cells that overlap with the therapeutic targets, thereby defining the cell-type–specific targets for Hepatoblastoma. Next, compute the average embedding of this overlapping set and calculate the cosine similarity between this reference vector and the embedding of each individual target. If one gene demonstrates a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PRUNE2', 'FERMT2', 'PDGFRB', 'TOX2', 'KCNMB1']",Hepatoblastoma,hepatic stellate cell,PDGFRB,"Which gene among PRUNE2, FERMT2, PDGFRB, TOX2, and KCNMB1 exhibits the highest cell-type specificity in hepatic stellate cells, making it the prime candidate for targeting hepatoblastoma?","Which gene among PRUNE2, FERMT2, PDGFRB, TOX2, and KCNMB1 exhibits the highest cell-type specificity in hepatic stellate cells, making it the prime candidate for targeting hepatoblastoma? Using verified therapeutic targets for Hepatoblastoma, retrieve their cell-type-specific embeddings from the PINNACLE database. Next, identify the intersection between these targets and hepatic stellate cell-activated genes in PINNACLE. For this overlapping set, compute an average embedding to serve as a reference, and then calculate the cosine similarity between this reference and each gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['MAN1A2', 'FCGBP', 'IL1RL1', 'TYMS', 'ENOX2']",Hepatoblastoma,hepatic stellate cell,TYMS,"Among MAN1A2, FCGBP, IL1RL1, TYMS, and ENOX2, which gene shows the highest specificity in hepatic stellate cells, making it the most promising target for hepatoblastoma therapy?","Among MAN1A2, FCGBP, IL1RL1, TYMS, and ENOX2, which gene shows the highest specificity in hepatic stellate cells, making it the most promising target for hepatoblastoma therapy? Identify the verified therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with hepatic stellate cell–activated genes in PINNACLE to define a set of cell-type–specific targets for hepatoblastoma. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this reference embedding and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PHLDB1', 'ERCC2', 'TOP2A', 'PPP6R1', 'TAF2']",Hepatoblastoma,hepatic stellate cell,TOP2A,"Among the genes PHLDB1, ERCC2, TOP2A, PPP6R1, and TAF2, which one exhibits the highest specificity in hepatic stellate cells, making it the best candidate for targeted hepatoblastoma therapy?","Among the genes PHLDB1, ERCC2, TOP2A, PPP6R1, and TAF2, which one exhibits the highest specificity in hepatic stellate cells, making it the best candidate for targeted hepatoblastoma therapy? Identify the verified therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the hepatic stellate cell-activated genes in PINNACLE to define the cell-type–specific targets for hepatoblastoma. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TUBB', 'FIS1', 'CSDE1', 'NYAP2', 'PSMA8']",Hepatoblastoma,hepatic stellate cell,TUBB,"Which gene from the set {TUBB, FIS1, CSDE1, NYAP2, PSMA8} demonstrates the highest specificity of expression in hepatic stellate cells, thereby serving as the most promising target for hepatoblastoma therapy?","Which gene from the set {TUBB, FIS1, CSDE1, NYAP2, PSMA8} demonstrates the highest specificity of expression in hepatic stellate cells, thereby serving as the most promising target for hepatoblastoma therapy? Identify the verified therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the hepatic stellate cell‐activated genes in PINNACLE. For the overlapping set, compute their average embedding and then calculate the cosine similarity between this average embedding and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OPRM1', 'NMUR1', 'TMF1', 'ZNF707', 'TOP2B']",Hepatoblastoma,hepatic stellate cell,TOP2B,"Which gene among OPRM1, NMUR1, TMF1, ZNF707, and TOP2B exhibits the highest specificity in hepatic stellate cells for the targeted treatment of hepatoblastoma?","Which gene among OPRM1, NMUR1, TMF1, ZNF707, and TOP2B exhibits the highest specificity in hepatic stellate cells for the targeted treatment of hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which hepatic stellate cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MTMR10', 'FANCM', 'SELENOF', 'IRX6', 'PRIM2']",Hepatoblastoma,hepatic stellate cell,PRIM2,"Among the genes MTMR10, FANCM, SELENOF, IRX6, and PRIM2, which one exhibits the most specific expression in hepatic stellate cells, making it the most promising candidate for targeted hepatoblastoma treatment?","Among the genes MTMR10, FANCM, SELENOF, IRX6, and PRIM2, which one exhibits the most specific expression in hepatic stellate cells, making it the most promising candidate for targeted hepatoblastoma treatment? Using validated therapeutic targets for Hepatoblastoma, retrieve their cell-type–specific embeddings from PINNACLE. Then, identify which of these targets overlap with the hepatic stellate cell-activated genes in PINNACLE to define the cell-type–specific list for Hepatoblastoma. Compute the average embedding of this overlap as a reference, and calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF226', 'TLR8', 'KNSTRN', 'ILVBL', 'TOP1']",Hepatoblastoma,hepatic stellate cell,TOP1,"Which gene, among ZNF226, TLR8, KNSTRN, ILVBL, and TOP1, exhibits the most specific expression in hepatic stellate cells, making it the optimal candidate for targeted hepatoblastoma therapy?","Which gene, among ZNF226, TLR8, KNSTRN, ILVBL, and TOP1, exhibits the most specific expression in hepatic stellate cells, making it the optimal candidate for targeted hepatoblastoma therapy? Identify the verified therapeutic targets for Hepatoblastoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with hepatic stellate cell–activated genes in PINNACLE; this overlapping set will serve as the Hepatoblastoma cell-type–specific targets. Compute the average embedding for this set, then calculate the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological significance."
"['TMEM70', 'SH3BP5L', 'PDGFRB', 'ABCB4', 'PTPN12']",Hepatoblastoma,hepatic stellate cell,PDGFRB,"Among TMEM70, SH3BP5L, PDGFRB, ABCB4, and PTPN12, which gene exhibits the greatest specificity in hepatic stellate cells, making it the most promising target for hepatoblastoma-directed interventions?","Among TMEM70, SH3BP5L, PDGFRB, ABCB4, and PTPN12, which gene exhibits the greatest specificity in hepatic stellate cells, making it the most promising target for hepatoblastoma-directed interventions? Identify validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the hepatic stellate cell-activated genes in PINNACLE. Calculate the average embedding for the overlapping set, then compute the cosine similarity between this reference embedding and each individual target embedding. If one gene shows a markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['IGF1R', 'UGDH', 'KIAA1958', 'KDF1', 'TUBB']",Hepatoblastoma,hepatic stellate cell,TUBB,"Among the genes IGF1R, UGDH, KIAA1958, KDF1, and TUBB, which one exhibits the highest cell type-specific expression in hepatic stellate cells for targeting hepatoblastoma?","Among the genes IGF1R, UGDH, KIAA1958, KDF1, and TUBB, which one exhibits the highest cell type-specific expression in hepatic stellate cells for targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which hepatic stellate cell–activated genes in PINNACLE overlap with these therapeutic targets, forming a set of cell-type–specific targets for hepatoblastoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['APOL3', 'TYMS', 'ABCG5', 'ZNF467', 'NFE2L3']",Hepatoblastoma,hepatic stellate cell,TYMS,"Among APOL3, TYMS, ABCG5, ZNF467, and NFE2L3, which gene demonstrates the highest specificity in hepatic stellate cells and appears most promising as a therapeutic target for hepatoblastoma?","Among APOL3, TYMS, ABCG5, ZNF467, and NFE2L3, which gene demonstrates the highest specificity in hepatic stellate cells and appears most promising as a therapeutic target for hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the hepatic stellate cell-activated genes in PINNACLE, thereby defining the cell-type–specific targets for hepatoblastoma. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this reference embedding and that of each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
